StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.15+0.03 (+2.68%)

Close on Nov 18, 2026Market cap $5.00MP/E –Yield –

BioLineRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioLineRx's shares outstanding was 2.66B at Jun 30, 2026. For fiscal 2025 it was 2.47B, up 105.8% from the year before. Over ten years it grew 47.3% a year on average. The highest annual figure on record is 2.47B in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252.47B+105.8%
FY2024Dec 31, 20241.20B+24.4%
FY2023Dec 31, 2023963M+24.5%
FY2022Dec 31, 2022774M+16.7%
FY2021Dec 31, 2021663M+162.2%
FY2020Dec 31, 2020253M+72.7%
FY2019Dec 31, 2019146M+34.8%
FY2018Dec 31, 2018109M+20.7%
FY2017Dec 31, 201790M+60.2%
FY2016Dec 31, 201656M+9.2%
FY2015Dec 31, 201551M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262.66B+272.5%
Q2 FY2025Jun 30, 20252.37B+254.1%
Q2 FY2024Jun 30, 20241.20B+443.6%
Q2 FY2023Jun 30, 2023923M+534.5%
Q2 FY2022Jun 30, 2022715M+570.9%
Q2 FY2021Jun 30, 2021669M+608.2%
Q2 FY2020Jun 30, 2020220M–
Q2 FY2019Jun 30, 2019145M–
Q2 FY2018Jun 30, 2018107M–
Q2 FY2017Jun 30, 201794M–

More BioLineRx figures

See a number that looks wrong?